Occudo Quantitative Strategies LP Paratek Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.67 - $2.51 $52,508 - $78,919	-31,442 Reduced 66.67%	15,722 $29,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $49,147 - $73,469	25,075 Added 113.52%	47,164 $121,000
Q2 2022 Aug 15, 2022	BUY	$1.73 - $3.09 $3,174 - $5,670	1,835 Added 9.06%	22,089 $43,000
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $59,546 - $96,611	20,254 New	20,254 $60,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $194,289 - $311,832	-28,530 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.14 - $8.31 $10,302 - $13,944	1,678 Added 6.25%	28,530 $201,000
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $122,982 - $191,723	26,852 New	26,852 $168,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.